| Title: |
Mitral Valve Intervention, Pulmonary Hypertension, and Survival in 219 Shone's Syndrome Patients. |
| Authors: |
Tucker, Dominique L.1,2 (AUTHOR); Gupta, Sohini1,2 (AUTHOR); Pande, Amol1,3 (AUTHOR); Mahboubi, Rashed1 (AUTHOR); Salim Hammoud, Miza1 (AUTHOR); Ahmad, Munir1,4 (AUTHOR); Najm, Hani1,4 (AUTHOR); Karamlou, Tara1,4 (AUTHOR) karamlt@ccf.org |
| Source: |
Annals of Thoracic Surgery. Jul2024, Vol. 118 Issue 1, p189-198. 10p. |
| Abstract: |
Relationships among pulmonary hypertension (PHTN), mitral valve intervention (MVI), and death in patients with Shone's syndrome (SS) are unclear. This study's recent data suggested temporal progression of mitral valve disease and an early survival benefit with MVI at initial operation. In this expanded cohort, the study characterized the trajectory and impact of PHTN on survival, as well as its relationship with MVIs. Study investigators conducted a record review of 219 patients with SS who underwent operation at a quaternary center between 1956 and 2022; 111 of these patients were pediatric (aged |
| Database: |
Supplemental Index |